Eton Pharmaceutcials
ETON
44 hedge funds and large institutions have $28.8M invested in Eton Pharmaceutcials in 2024 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 12 increasing their positions, 13 reducing their positions, and 13 closing their positions.
0.06% more ownership
Funds ownership: 29.81% → 29.87% (+0.06%)
8% less repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 13
14% less capital invested
Capital invested by funds: $33.5M → $28.8M (-$4.74M)
21% less funds holding
Funds holding: 56 → 44 (-12)
85% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 13
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$785K |
| 2 |
Goldman Sachs
New York
|
+$519K |
| 3 |
AI
Acuitas Investments
Seattle,
Washington
|
+$384K |
| 4 |
SSA
Schonfeld Strategic Advisors
New York
|
+$168K |
| 5 |
Renaissance Technologies
New York
|
+$97.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Ameriprise
Minneapolis,
Minnesota
|
-$709K |
| 2 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$367K |
| 3 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$142K |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
-$123K |
| 5 |
SWP
Stratos Wealth Partners
Beachwood,
Ohio
|
-$118K |
ETON Hedge Fund Activity: Q1 2024 in Review
44 of the 6,958 institutional investors tracked by Wall St. Rank reported a position in Eton Pharmaceutcials (ETON) for Q1 2024, worth a combined $28.8M — down 14% from $33.5M a quarter earlier.
Sellers outnumbered buyers: 13 funds closed out of ETON and 2 opened new positions — a net loss of 11 holders — while 13 trimmed existing stakes and 12 added.
The largest buyer was Susquehanna International Group, adding an estimated $785K. The largest seller was Ameriprise, exiting entirely with an estimated $709K sold.
- 44 institutional investors held Eton Pharmaceutcials (ETON) as of Q1 2024, down from 56 in Q4 2023.
- Funds reported $28.8M of Eton Pharmaceutcials stock for Q1 2024, down 14% quarter-over-quarter.
- 2 funds opened new Eton Pharmaceutcials positions in Q1 2024 and 13 closed out, a net change of -11 holders.
- The largest Eton Pharmaceutcials buyer in Q1 2024 was Susquehanna International Group, an estimated $785K added.
- The largest Eton Pharmaceutcials seller in Q1 2024 was Ameriprise, an estimated $709K sold.
Based on aggregated 13F filings for Q1 2024.